WYNZORA® is a topical treatment of mild to moderate psoriasis in adults, including scalp2
Click SmPC for details in MS Word format
Introducing PAD Technology
WYNZORA formulation is based on PAD technology which offers an appealing cream of high cosmetic quality and patient acceptability.
Request a Demo or Sample Kit
- Stein Gold L, Green LJ, Dhawan S, et al. A Phase 3, Randomized Trial Demonstrating the Improved Efficacy and Patient Acceptability of Fixed Dose Calcipotriene and Betamethasone Dipropionate Cream. J Drugs Dermatol. 2021;20(4):420-425.